Condensed Consolidated Statements of Operations and Comprehensive Loss (USD $) In Thousands, except Per Share data, unless otherwise specified	3 Months Ended
	Sep. 30, 2013	Sep. 30, 2012
Income Statement [Abstract]
Operating revenues (net of contractual allowances)	$ 28,296	$ 29,172
Less provision for bad debts of Healthcare Facilities Segment	2,718	3,482
Net revenues	25,578	25,690
Costs and Expenses
Cost of goods sold	4,275	4,237
Salaries, wages and benefits	12,987	13,221
Provision for bad debts of Specialty Pharmacy Segment	53	80
Supplies	2,197	2,263
Purchased services	1,851	1,956
Other operating expenses	3,711	4,105
Rent and lease expense	461	546
Impairment of property, plant and equipment	0	789
Depreciation and amortization	907	984
Operating Loss	(864)	(2,491)
Other Expense:
Interest expense-net	(312)	(559)
Loss from Continuing Operations before income taxes	(1,176)	(3,050)
Income Tax Benefit	(2)	(1,428)
Loss from Continuing Operations	(1,174)	(1,622)
Earnings from Discontinued Operations, net of tax	16	198
Net Loss	(1,158)	(1,424)
Other comprehensive income	0	0
Comprehensive Loss	$ (1,158)	$ (1,424)
Continuing Operations:
Basic	$ (0.12)	$ (0.17)
Diluted	$ (0.12)	$ (0.17)
Discontinued Operations:
Basic	$ 0.00	$ 0.02
Diluted	$ 0.00	$ 0.02
Net Loss:
Basic	$ (0.12)	$ (0.15)
Diluted	$ (0.12)	$ (0.15)
Weighted-Average Common Shares Outstanding:
Basic	9,443	9,446
Diluted	9,443	9,446